Abeona Therapeutics Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 15 →InsidersNo open-market buys. 9 insiders sold $2.4M, 6 of 28 sales on a 10b5-1 plan.→HoldersNantahala 18.0%BlackRock 5.9%Cable Car Capital 5.3%→PeersClosest companies: CLDI, FDMT, IRD→
From the filings
Figures
- Revenue
- $5.8Mlast 12 months
- Net income
- −$205.3Mlast 12 months
- Operating cash flow
- −$77.7Mlast 12 months
- Cash and equivalents
- $56.2Mat the last balance sheet
- Total debt
- $15.0Mat the last balance sheet
- Shares outstanding
- 57.2M shareson issue